Your browser doesn't support javascript.
loading
The NKT cell ligand αgalactosylceramide suppresses allergic airway inflammation by induction of a Th1 response.
Knothe, S; Mutschler, V; Rochlitzer, S; Winkler, C; Ebensen, T; Guzman, C A; Hohlfeld, J; Braun, A; Muller, M.
Affiliation
  • Knothe S; Fraunhofer Institute for Toxicology and Experimental Medicine, Department of Immunology, Allergology and Immunotoxicology, Nikolai-Fuchs-Str. 1, 30625 Hannover, Germany.
Vaccine ; 29(25): 4249-55, 2011 Jun 06.
Article in En | MEDLINE | ID: mdl-21463684
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Th1 Cells / Natural Killer T-Cells / Galactosylceramides / Hypersensitivity / Immunologic Factors / Inflammation Type of study: Prognostic_studies Limits: Adolescent / Adult / Animals / Female / Humans / Male / Middle aged Language: En Journal: Vaccine Year: 2011 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Th1 Cells / Natural Killer T-Cells / Galactosylceramides / Hypersensitivity / Immunologic Factors / Inflammation Type of study: Prognostic_studies Limits: Adolescent / Adult / Animals / Female / Humans / Male / Middle aged Language: En Journal: Vaccine Year: 2011 Document type: Article Affiliation country: Country of publication: